(Q36781531)

English

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

scientific article published on December 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

anti-retroviral agent

0 references

19

object named as

A S Fauci

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

H. Clifford Lane

20

object named as

H C Lane

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

R T Davey

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

N Bhat

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

C Yoder

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

T W Chun

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

J A Metcalf

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R Dewar

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

V Natarajan

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R A Lempicki

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

J W Adelsberger

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

K D Miller

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

J A Kovacs

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

M A Polis

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

R E Walker

13

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

J Falloon

14

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

H Masur

15

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

D Gee

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

M Baseler

17

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

D S Dimitrov

18

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

96

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

26

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

15109-15114

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Early establishment of a pool of latently infected, resting CD4 + T cells during primary HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Treatment of HIV infection. Tolerability of commonly used antiretroviral agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

29 September 2017

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

27 June 2018

Declining HIV/AIDS mortality in New York City

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

27 June 2018

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

27 June 2018

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

27 June 2018

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

Rate of HIV-1 RNA rebound upon stopping antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

Toward HIV Eradication or Remission: The Tasks Ahead

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

5 September 2018

Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among physicians and patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

20 October 2018

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

4 December 2018

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

4 December 2018

Therapeutic Strategies for HIV Infection — Time to Think Hard

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=24781

4 December 2018

Re-emergence of HIV after stopping therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visceral abdominal-fat accumulation associated with use of indinavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction-maintenance antiretroviral therapy: proof of concept

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10611346

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.96.26.15109

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1999PNAS...9615109D

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36781531&oldid=2099447000"